• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

ML188 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759175

ML188 is a selective noncovalent SARS-CoV 3CLpro inhibitor(IC50 : 1.5uM), with moderate MW and good enzyme and antiviral inhibitory activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
ML188, Inhibitor
Full Product Name
ML188
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.04%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
433.54
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C26H31N3O3
SMILES
CC(C)(C)NC(=O)[C@H](N(C(=O)c1ccco1)c1ccc(cc1)C(C)(C)C)c1cccnc1
CAS Number
1417700-13-0
Target & IC50
SARS-CoV: ic50 1.5uM
In Vitro
Probe 16-(R) (ML188) is a modest molecular weight SARS-CoV 3CLpro inhibitor with demonstrated antiviral activity and a non-covalent mechanism of action[1].

Product Categories/Family for ML188, inhibitor

Structure of ML188, inhibitor

ML188 Inhibitor – Cat# MBS5759175

Product References and Citations for ML188, inhibitor

Jacobs J, Grum-Tokars V, Zhou Y, et al. Discovery, Synthesis, And Structure-Based Optimization of a Series of N -( tert -Butyl)-2-( N -arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease[J]. Journal of Medicinal Chemistry, 2013, 56(2):534-546.
Jacobs J, Grum-Tokars V, Zhou Y, et al. Discovery, Synthesis, And Structure-Based Optimization of a Series of N -( tert -Butyl)-2-( N -arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease[J]. Journal of Medicinal Chemistry, 2013, 56(2):534-546.
Michael Berry, Burtram Fielding, Junaid Gamieldien.Human Coronavirus OC43 3CL Protease and the Potential of ML188 as a Broad-Spectrum Lead Compound: Homology Modelling and Molecular Dynamic Studies[J]. BMC Struct Biol. 2015 Apr 28;15:8.
Michael Berry, Burtram Fielding, Junaid Gamieldien.Human Coronavirus OC43 3CL Protease and the Potential of ML188 as a Broad-Spectrum Lead Compound: Homology Modelling and Molecular Dynamic Studies[J]. BMC Struct Biol. 2015 Apr 28;15:8.

Other Notes

Small volumes of ML188, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for ML188 purchase

MBS5759175 is an inhibitor targeting ML188.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000